Unit of Reproductive Endocrinology, First Department of Obstetrics and Gynecology, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Fertil Steril. 2011 Sep;96(3):780-5. doi: 10.1016/j.fertnstert.2011.06.020. Epub 2011 Jul 13.
To review the evidence regarding thyroid function and thyroid autoimmunity (TAI) changes in women undergoing ovarian stimulation (OS).
Studies eligible for the systematic review were those that reported data on thyroid function or TAI both before and during OS or within 1 month after OS.
Academic hospital.
PATIENT(S): Women with abnormal thyroid function or TAI (n = 419) and controls (n = 425).
INTERVENTION(S): Ovarian stimulation.
MAIN OUTCOME MEASURE(S): Serum TSH, free thyroxine, free tri-iodothyronine and thyroid antibodies.
RESULT(S): Seven studies, between 2000 and 2011, were included. Serum TSH concentrations were significantly increased in three studies and were not changed in two studies. Serum free thyroxine concentrations were increased in two studies, were not changed in one, and were decreased in another. Serum free tri-iodothyronine concentrations were not changed in the only study in which they were measured. Thyroid antibody concentrations were decreased in one study and were not changed in two studies, even in the presence of changes in thyroid function.
CONCLUSION(S): The current evidence is inconclusive regarding OS effect on thyroid function or TAI. Serum TSH concentrations may be increased during or within 1 month after OS, exceeding the threshold of 2.5 mU/L suggested for the first trimester of pregnancy, but further prospective studies are needed to provide conclusive evidence for or against universal evaluation of thyroid function and TAI in women undergoing OS.
综述卵巢刺激(OS)过程中女性甲状腺功能和甲状腺自身免疫(TAI)变化的证据。
符合系统综述标准的研究应报告 OS 前后或 OS 后 1 个月内甲状腺功能或 TAI 的相关数据。
学术医院。
甲状腺功能异常或 TAI 的女性(n=419)和对照组(n=425)。
卵巢刺激。
血清 TSH、游离甲状腺素、游离三碘甲状腺原氨酸和甲状腺抗体。
纳入 7 项研究,时间跨度为 2000 年至 2011 年。3 项研究发现血清 TSH 浓度显著升高,2 项研究未发现变化。2 项研究发现血清游离甲状腺素浓度升高,1 项研究未发现变化,另 1 项研究发现降低。唯一测量了血清游离三碘甲状腺原氨酸的研究发现其浓度没有变化。1 项研究发现甲状腺抗体浓度降低,2 项研究未发现变化,尽管甲状腺功能发生了变化。
目前的证据无法确定 OS 对甲状腺功能或 TAI 的影响。OS 过程中或 OS 后 1 个月内,血清 TSH 浓度可能会升高,超过妊娠早期 2.5 mU/L 的建议阈值,但需要进一步的前瞻性研究来提供确凿的证据,证明或反驳对接受 OS 的女性进行甲状腺功能和 TAI 普遍评估的合理性。